Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it takes to recover from RSV. But children under 5 and adults 60 and older are at high risk of severe infection resulting in hospitalization. The latter are also in danger of death.
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older first received the shot.
RSV Vaccine in Older Adults Reduces Risk for Infection, Hospitalization
RSV vaccination was associated with decreased risks for infection and hospitalization, although the decrease was not statistically significant.
GSK RSV vaccine data suggest protection across 3 seasons
The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.
Making an RSV Vaccine Was Hard. Getting People to Take It Is Even Harder
RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are already huge inequities in access and uptake.
Alberta to cover pricey RSV vaccine for some older people
The Alberta government announced Monday that the RSV vaccine, Abyrsvo, will be provincially funded for Albertans, aged 60 and up, who live in continuing care and supportive living homes. Limited supplies of the provincially funded vaccine will also be available to people 75 and older, who live in the community.
What to know about COVID, flu and RSV vaccines for fall virus season
Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.
What to know about the RSV vaccine ahead of virus season
Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.
1d
on MSN
Yes, you can get the COVID, flu, and RSV vaccines at once. Here are the pros and cons
You may have been too young to remember, but depending on your state’s school immunization requirements, you likely received ...
1d
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
Poynter
13d
Older adults are at risk for RSV. Here’s how journalists can help keep them safe.
Poynter has partnered with the Risk Less. Do More. campaign to host a webinar, articles to better inform journalists.
thecardiologyadvisor.com
9h
RSV Vaccine Is Recommended for Long-Term Care Facility Residents
The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.
STAT
5d
After a rocky debut for new RSV tools, hopes are high as a new season approaches
Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...
Malay Mail on MSN
6d
GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback